scroll to top
0

EBSCO Auth Banner

Let's find your institution. Click here.

Advanced Search Results For "Gosling, Emily"

Filter
1 - 10 of 1,545 results for
 "Gosling, Emily"
Results per page:
Sort By:
Your filters
  • Filter by:
  • Reset filters

    • Breast calcification chemistry as a biomarker for progression of in-situ breast cancer

    Publication Type: Academic Journal

    Source(s): Bone Reports, Vol 14, Iss , Pp 100787- (2021)

    Study protocol for a cluster-randomized split-plot design trial to assess the effectiveness of targeted active malaria case detection among high-risk populations in Southern Lao PDR (the AcME-Lao study) [version 1; peer review: 2 approved]

    Publication Type: Academic Journal

    Source(s): Gates Open Research, Vol 3 (2019)

    Abstract: Introduction: Novel interventions are needed to accelerate malaria elimination, especially in areas where asymptomatic parasitemia is common, and where transmission generally occurs outside of village-based settings. Testing of community members linked...

    Subjects:

    International Perceptions of Urban Blue-Green Infrastructure: A Comparison across Four Cities

    Publication Type: Academic Journal

    Source(s): Water, Vol 13, Iss 544, p 544 (2021)

    Abstract: Blue-Green infrastructure (BGI) is recognised internationally as an approach for managing urban water challenges while enhancing society and the environment through the provision of multiple co-benefits. This research employed an online survey to inves...

    Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    Publication Type: Periodical

    Source(s): The Lancet; February 2022, Vol. 399 Issue: 10325 p665-676, 12p

    Abstract: Casirivimab and imdevimab are non-competing monoclonal antibodies that bind to two different sites on the receptor binding domain of the SARS-CoV-2 spike glycoprotein, blocking viral entry into host cells. We aimed to evaluate the efficacy and safety o...

    Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    Publication Type: Periodical

    Source(s): The Lancet; January 2022, Vol. 399 Issue: 10320 p143-151, 9p

    Abstract: Aspirin has been proposed as a treatment for COVID-19 on the basis of its anti-thrombotic properties. We aimed to evaluate the efficacy and safety of aspirin in patients admitted to hospital with COVID-19.

    Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

    Publication Type: Periodical

    Source(s): The Lancet; May-June 2021, Vol. 397 Issue: 10289 p2049-2059, 11p

    Abstract: Many patients with COVID-19 have been treated with plasma containing anti-SARS-CoV-2 antibodies. We aimed to evaluate the safety and efficacy of convalescent plasma therapy in patients admitted to hospital with COVID-19.

    Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    Publication Type: Periodical

    Source(s): The Lancet; May 2021, Vol. 397 Issue: 10285 p1637-1645, 9p

    Abstract: In this study, we aimed to evaluate the effects of tocilizumab in adult patients admitted to hospital with COVID-19 with both hypoxia and systemic inflammation.

    Discovery of Icenticaftor (QBW251), a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator with Clinical Efficacy in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease

    Publication Type: Periodical

    Source(s): Journal of Medicinal Chemistry; June 2021, Vol. 64 Issue: 11 p7241-7260, 20p

    Abstract: Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) ion channel are established as the primary causative factor in the devastating lung disease cystic fibrosis (CF). More recently, cigarette smoke exposure has been shown to be a...

    Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    Publication Type: Periodical

    Source(s): The Lancet; February 2021, Vol. 397 Issue: 10274 p605-612, 8p

    Abstract: Azithromycin has been proposed as a treatment for COVID-19 on the basis of its immunomodulatory actions. We aimed to evaluate the safety and efficacy of azithromycin in patients admitted to hospital with COVID-19.

    Hope in a Hostile World.

    Publication Type: Periodical

    Source(s): Elephant; Spring/Summer2021, Issue 45, p104-115, 12p, 7 Color Photographs

    Authors:
    Subjects:
    sponsored